Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
- 3 October 2016
- journal article
- case report
- Published by Springer Nature in International Journal of Hematology
- Vol. 105 (1) , 104-108
Abstract
The skin is a possible site of extramedullary localization in multiple myeloma (MM) patients; however, the mechanisms involved in this process are poorly understood. We describe the case of a refractory MM patient who developed a cutaneous localization under bortezomib treatment and we further expanded observations in other eight MM patients. We focused on the expression of genes involved in plasma cell skin homing, including CCR10, which was highly expressed. Moreover, we observed a lack of CXCR4 surface expression and the down-regulation of ICAM1/CD54 throughout the progression of the disease, suggesting a possible mechanism driving the escape of MM cells from the bone marrow into the skin.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (15531, 10136)
- Fondazione Italiana per la Ricerca sul Cancro (18152)
- Ministero della Salute (E66110000230001)
This publication has 22 references indexed in Scilit:
- Disentangling the microRNA regulatorymilieuin multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patientsOncotarget, 2015
- Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide–bortezomib combinationsBritish Journal of Haematology, 2015
- Extramedullary disease in multiple myeloma in the era of novel agentsBritish Journal of Haematology, 2015
- Discordant Immunophenotypic Profiles of Adhesion Molecules and Cytokines in Acute Myeloid Leukemia Involving Bone Marrow and SkinAmerican Journal of Clinical Pathology, 2012
- Targeting the interplay between myeloma cells and the bone marrow microenvironment in myelomaInternational Journal of Hematology, 2011
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myelomaOncogene, 2008
- Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myelomaBlood, 2006
- Presence of Circulating CCR10+ T cells and Elevated Serum CTACK/CCL27 in the Early Stage of Mycosis FungoidesClinical Cancer Research, 2006
- Plasma Cell ProblemsJournal of Clinical Oncology, 2005
- Cutaneous Involvement in Multiple MyelomaArchives of Dermatology, 2003